blog
September 19, 2024 – Founded in 2016, FITCI Grad Theradaptive is growing again. The company is commercializing a pipeline of therapeutics in the orthopedic space, targeting multiple clinical applications, including … Read more
Exploring InfoPathways and their remarkable support of FITCI and the entrepreneurs we serve! This partnership, sparked by a referral, has blossomed into a powerful alliance, showcasing InfoPathways’ unwavering commitment to … Read more
By Anna Eyler In a rapidly evolving business landscape, startups that don’t consider implementing emerging technologies like artificial intelligence (AI) and robotics into their operations are at risk of being … Read more
By Anna Eyler Circular business practices revolutionize industries, mitigate environmental impact, minimize waste generation, achieve cost reductions, and drive sustainable innovation for a brighter future. In a circular economy, materials … Read more
Experience the Future in Every Dimension at FITCI’s spectacular launch celebration of Maryland’s EDGE at 321 Ballenger Center Drive in Frederick, Maryland. Join the journey into the future of innovation … Read more
An enduring affiliation – from FITCI’s founding to forging ahead Dan Brower knows a thing or two about laboratories – specifically, outfitting them for maximum efficiency, even on a budget. … Read more
FITCI begins transition to new facility, offers community tours Rounding into phase 1 completion of the area’s newest entrepreneurial community space at the EDGE at 321, FITCI achieved move-in approval … Read more
Wednesday, January 17th, 2024 – Accredited Biotech/Biomedical investors gathered in Tysons Corner, Virginia, for a private, in-person presentation and dinner featuring FITCI startup client BioSolution Designs, Inc. (BSD), thanks to … Read more
FITCI Grad builds upon an unprecedented three Breakthrough Medical Device designations by the FDA Theradaptive, a leading biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded a … Read more
